|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
2
|
|
pubmed:dateCreated |
2006-7-3
|
|
pubmed:abstractText |
Although prostate cancer specific mortality is decreasing, there is little effect on overall mortality in this population, suggesting the possibility of an increased risk of death from nonprostate cancer related causes. Androgen deprivation therapy could adversely affect cardiovascular health. We investigated changes in lipid and glucose during androgen deprivation therapy.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Androgen Antagonists,
http://linkedlifedata.com/resource/pubmed/chemical/Anilides,
http://linkedlifedata.com/resource/pubmed/chemical/Antineoplastic Agents, Hormonal,
http://linkedlifedata.com/resource/pubmed/chemical/Blood Glucose,
http://linkedlifedata.com/resource/pubmed/chemical/Cholesterol,
http://linkedlifedata.com/resource/pubmed/chemical/Gonadotropin-Releasing Hormone,
http://linkedlifedata.com/resource/pubmed/chemical/Leuprolide,
http://linkedlifedata.com/resource/pubmed/chemical/Nitriles,
http://linkedlifedata.com/resource/pubmed/chemical/Oligopeptides,
http://linkedlifedata.com/resource/pubmed/chemical/Tosyl Compounds,
http://linkedlifedata.com/resource/pubmed/chemical/abarelix,
http://linkedlifedata.com/resource/pubmed/chemical/bicalutamide
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Aug
|
|
pubmed:issn |
0022-5347
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
176
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
520-5
|
|
pubmed:dateRevised |
2007-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:16813881-Androgen Antagonists,
pubmed-meshheading:16813881-Anilides,
pubmed-meshheading:16813881-Antineoplastic Agents, Hormonal,
pubmed-meshheading:16813881-Blood Glucose,
pubmed-meshheading:16813881-Cholesterol,
pubmed-meshheading:16813881-Fasting,
pubmed-meshheading:16813881-Gonadotropin-Releasing Hormone,
pubmed-meshheading:16813881-Humans,
pubmed-meshheading:16813881-Leuprolide,
pubmed-meshheading:16813881-Male,
pubmed-meshheading:16813881-Middle Aged,
pubmed-meshheading:16813881-Nitriles,
pubmed-meshheading:16813881-Oligopeptides,
pubmed-meshheading:16813881-Prostatic Neoplasms,
pubmed-meshheading:16813881-Tosyl Compounds
|
|
pubmed:year |
2006
|
|
pubmed:articleTitle |
The effect of androgen deprivation therapy on fasting serum lipid and glucose parameters.
|
|
pubmed:affiliation |
Beth Israel Deaconess Medical Center, Waltham, Massachusetts 02215, USA.
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
